- |||||||||| berdazimer sodium (SB204) / Sato Pharma, Novan
Clinical: P3 Long Term Safety Study of Once Daily SB204 in Acne (clinicaltrials.gov) - Aug 3, 2016 P3, N=605, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| Phase classification, Enrollment change, Trial primary completion date: Autologous Fibroblast Transplantation in Facial Deformities (clinicaltrials.gov) - Jul 23, 2016
P2, N=60, Completed, N=30 --> 0 | Not yet recruiting --> Withdrawn Phase classification: P2/3 --> P2 | N=40 --> 60 | Trial primary completion date: Sep 2010 --> Sep 2015
- |||||||||| benzoyl peroxide/clindamycin / Generic mfg.
Trial completion: DUAC (clinicaltrials.gov) - Apr 11, 2016 P4, N=350, Completed, Initiation date: Feb 2016 --> May 2016 Active, not recruiting --> Completed
- |||||||||| finasteride / Generic mfg.
Trial primary completion date: Finasteride Treatment of Severe Nodulocystic Acne (clinicaltrials.gov) - Apr 6, 2016 P2, N=180, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Mar 2016 --> Dec 2016
- |||||||||| Enrollment change, Trial termination: Safety Study of Plasma Treatment System to Treat Back Acne (clinicaltrials.gov) - Mar 23, 2016
P=N/A, N=8, Terminated, Recruiting --> Active, not recruiting | N=10 --> 12 N=12 --> 8 | Recruiting --> Terminated; The study was stopped due to other research priorities.
- |||||||||| Enrollment change, Trial termination: Impact of the M22-IPL Acne Filter on Acne Vulgaris (clinicaltrials.gov) - Mar 18, 2016
P=N/A, N=13, Terminated, N=12 --> 8 | Recruiting --> Terminated; The study was stopped due to other research priorities. N=20 --> 13 | Recruiting --> Terminated; Low recruiting rate
|